HeimMRK • NYSE
add
Merck & Co Inc
82,39 $
Eftir lokun(0,027%)+0,022
82,41 $
Lokað: 2. júl., 19:44:55 GMT-4 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
81,81 $
Dagbil
81,89 $ - 82,81 $
Árabil
73,31 $ - 129,93 $
Markaðsvirði
206,88 ma. USD
Meðalmagn
16,46 m.
V/H-hlutf.
11,99
A/V-hlutfall
3,93%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | mar. 2025info | Breyting á/á |
---|---|---|
Tekjur | 15,53 ma. | -1,56% |
Rekstrarkostnaður | 5,92 ma. | 4,83% |
Nettótekjur | 5,08 ma. | 6,66% |
Hagnaðarhlutfall | 32,71 | 8,35% |
Hagnaður á hvern hlut | 2,22 | 7,25% |
EBITDA | 7,28 ma. | -4,45% |
Virkt skatthlutfall | 13,86% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | mar. 2025info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 9,23 ma. | 64,23% |
Heildareignir | 115,12 ma. | 8,76% |
Heildarskuldir | 66,72 ma. | 1,98% |
Eigið fé alls | 48,40 ma. | — |
Útistandandi hlutabréf | 2,51 ma. | — |
Eiginfjárgengi | 4,26 | — |
Arðsemi eigna | 13,39% | — |
Ávöxtun eigin fjár | 18,53% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | mar. 2025info | Breyting á/á |
---|---|---|
Nettótekjur | 5,08 ma. | 6,66% |
Handbært fé frá rekstri | 2,50 ma. | -19,09% |
Reiðufé frá fjárfestingum | -1,49 ma. | -8,07% |
Reiðufé frá fjármögnun | -5,76 ma. | -104,51% |
Breyting á handbæru fé | -4,59 ma. | -270,44% |
Frjálst peningaflæði | 760,50 m. | -48,11% |
Um
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Framkvæmdastjóri
Stofnsett
1. jan. 1891
Vefsvæði
Starfsfólk
74.000